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Objectives.To describemortality among adults with intellectual disability in England in
comparison with the general population.
Methods. We conducted a cohort study from 2009 to 2013 using data from 343
general practices. Adults with intellectual disability (n = 16 666; 656 deaths) were
compared with age-, gender-, and practice-matched controls (n = 113562; 1358 deaths).
Results. Adults with intellectual disability had higher mortality rates than controls
(hazard ratio [HR] = 3.6; 95% conﬁdence interval [CI] = 3.3, 3.9). This risk remained high
after adjustment for comorbidity, smoking, and deprivation (HR = 3.1; 95%CI = 2.7, 3.4);
it was even higher among adults with intellectual disability and Down syndrome or
epilepsy. A total of 37.0% of all deaths among adults with intellectual disability were
classiﬁed as being amenable to health care intervention, compared with 22.5% in the
general population (HR = 5.9; 95% CI = 5.1, 6.8).
Conclusions. Mortality among adults with intellectual disability is markedly ele-
vated in comparison with the general population, with more than a third of deaths
potentially amenable to health care interventions. This mortality disparity sug-
gests the need to improve access to, and quality of, health care among people with
intellectual disability. (Am J Public Health. 2016;106:1483–1490. doi:10.2105/
AJPH.2016.303240)
People with intellectual disabilityexperience poorer physical health and
receive poorer quality health care than people
without intellectual disability for a range of
reasons, including discrimination.1 These
inequalities are a concern for health care
systems in the United Kingdom, the United
States, and other developed countries, where
the prevalence of intellectual disability has
been estimated at approximately 1%.2 Studies
have reported that people with intellectual
disability experience high mortality rates,
shorter life expectancies, and excess pre-
mature mortality, with variable estimates
of increased risk of death ranging between
3 and 18 times higher than those of the general
population.3–6 A national conﬁdential in-
quiry into premature deaths among people
with intellectual disability in the United
Kingdomhighlighted the potential to prevent
premature mortality,7 concluding that people
with intellectual disability die on average
16 years earlier than the general population
and that potentially modiﬁable poor care
and service provision contributes to this
mortality gap.
The lack of reliable information on the
health experience of people with intellectual
disability has been identiﬁed as an important
barrier to developing effective health care
strategies for this group.8 According to theUS
Public Health Service, it has been unable to
report on the health status of individuals with
intellectual disability, one of its most
vulnerable populations, on a truly represen-
tational basis.9 In other populations, an
understanding of mortality patterns, espe-
cially cause-speciﬁc and potentially avoidable
mortality, has been a driver in developing
priorities for health care interventions and
monitoring the effectiveness of health
services.
Unfortunately, as a result of incomplete
recording of intellectual disability on death
certiﬁcates and difﬁculties in relating death
certiﬁcate data to a particular population
at risk, studies based on death certiﬁcation
data alone are inadequate for understanding
the mortality experience of people with
intellectual disability.10 Other studies are
often based on local registers and may not
be representative,3 or they may be based on
smaller samples with long follow-ups andmay
therefore no longer be contemporary.5
Linkages between data sources that record
mortality and those that identify people
with intellectual disability have the potential
to yield accurate evidence on health and
mortality disparities.8
We used a large English primary care
database, linked to death certiﬁcation data,
to describe mortality rates between 2009
and 2013 in a group of adults with intellectual
disability and to compare these rates with
those found in the general population.
We assessed all-causemortality, cause-speciﬁc
mortality, and mortality considered
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potentially avoidable through medical
intervention.
METHODS
We derived our data from the Clinical
Practice Research Datalink, a large, validated
primary care database that has been shown to
be representative of the UK population,11
98% of whom are registered with a general
(family) practitioner. In our analyses, we
included 343 English practices that were
recording data on January 1, 2009, and were
anonymously linked to Ofﬁce of National
Statistics (ONS) death registration data.
Identiﬁcation of Patients With
Intellectual Disability
In England, people with intellectual
disability live almost exclusively in the
community, either in private households or
in communal or shared settings. Since 2006,
doctors have been ﬁnancially incentivized
to electronically maintain a register of all
adults with intellectual disability in their
practice.12 We used nationally agreed-upon
codes for intellectual disability, along with
a few additional codes for chromosomal and
metabolic disorders usually associated with
intellectual disability, to identify patients.13
Our sample comprised 16 666 patients, 18
to 84 years of age, who were registered for
more than 30 days between 2009 and 2013.
We identiﬁed some important subgroups
that could be easily identiﬁed from primary
care records: Down syndrome patients,
patients with epilepsy in addition to
intellectual disability, intellectual disability
patients with autistic spectrum disorder,
intellectual disability patients with high levels
of support needs, and intellectual disability
patients living in a communal or shared
setting. We classiﬁed patients as having
high levels of support needs if they had
a record of severe or profound intellectual
disability or, in cases in which no record of
severitywas available (59%), they had at least 2
of the following: cerebral palsy or signiﬁcant
mobility problems (e.g., wheelchair use),
severe visual impairment, severe hearing
impairment, epilepsy (excluding absence
seizures), continence problems, and
percutaneous endoscopic gastrostomy
feeding. We assessed communal living
arrangements by searching for speciﬁc codes
or the presence of 3 or more people with
intellectual disability with the same address
ﬂag, indicating that they were living at the
same address.
Study Design
Our study involved a retrospective
matched cohort design. Adults with
intellectual disability were followed from
the latest date available of the following:
January 1, 2009; January 1 of the year of their
18th birthday; or their date of registration.
They were followed until the earliest date
of recording of death, deregistration from
practice, or when the practice stopped
providing data to the Clinical Practice
Research Datalink (up to March 31, 2013).
We compared them with up to 7 age-,
gender-, and practice-matched individuals
with no record of intellectual disability
(control group; n = 113 562) who were
registered at the beginning of the study
period. The average length of follow-up
for all patients in our cohort was approxi-
mately 3 years (1097 days).
Cause of Death
We derived information on underlying
cause of death from ONS death registration
data for patients who died during the
study (656 adults with intellectual disability,
1358 control group members). In the case
of 38 of these deaths, we were unable to
obtain data on cause of death. We summa-
rized main causes of death using chapter
headings from the International Classiﬁcation
of Diseases, 10th Revision,14 but also
explored some subgroups of interest. When
examining how often intellectual disability
was recorded on death certiﬁcates, we
searched all recorded main and contributory
causes of death for intellectual disability–
associated codes, including an extended range
of conditions weakly associated with in-
tellectual disability such as cerebral palsy.10
Potentially Avoidable Deaths and
Mortality Amenable to Care
In the United Kingdom, the ONS has
deﬁned indicators of potentially avoidable
mortality to assess whether prior intervention
for the underlying cause of death would
reducemortality for certain conditions.15 The
ONS deﬁnes deaths as potentially avoidable
(according to underlying cause of death)
when there is scope for intervention to reduce
mortality.15 Potentially avoidable deaths are
further classiﬁed as amenable to good-quality
health care (treatable), preventable through
public health action, or both. With the
exception of accidental deaths, these
deﬁnitions primarily include deaths occurring
among individuals younger than 75 years.
For example, deaths from breast cancer are
identiﬁed as amenable to health care, through
screening and treatment, and deaths from
lung cancer are identiﬁed as preventable,
through tobacco control. Because some
causes of death are deﬁned as both amenable
and preventable (e.g., ischemic heart disease),
the number of deaths that are potentially
avoidable is lower than the combined number
of deaths that are amenable and preventable.
Adjustment for Comorbidities and
Other Factors
We present unadjusted and adjusted
comparisons. However our unadjusted
analyses already adjusted for differences in
our matched factors: age, gender, and practice
(including regional and urban–rural varia-
tions). In addition, we adjusted comparisons
between adults with intellectual disability and
control group members using 9 comorbid
conditions that are independent predictors
of mortality in the general population16:
atrial ﬁbrillation, cancer, chronic obstructive
pulmonary disease, dementia, diabetes,
epilepsy, heart failure, severe mental illness
(psychosis, schizophrenia, bipolar affective
disorder), and stroke. English general
practices are encouraged to use nationally
agreed-upon codes12 to record these condi-
tions, and we identiﬁed these codes in
patients’ records before their study entry
date. We favored this approach over the
Charlson index, which does not account for
epilepsy or severe mental illness, both of
which are much more common among
adults with intellectual disability.13
Other covariates of interest were smoking
and socioeconomic status. In computing
the latter, we used the Index of Multiple
Deprivation,17 a composite small-area
ecological measure of deprivation based on
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postcodes. A summary of comorbidity,
smoking, and deprivation data among
adults with intellectual disability and controls
is provided in Table A, available as a supple-
ment to the online version of this article at
http://www.ajph.org.
Statistical Analysis
We present crude death rates and
hazard ratios (HRs) for comparisons between
adults with intellectual disability and matched
controls. Hazard ratios were calculated
via Cox regression (SAS version 9.4; SAS
Institute Inc, Cary, NC), with further ad-
justment for covariates (on a multiplicative
scale) and stratiﬁcation on matched sets
(i.e., matched according to gender, age,
and practice). For subgroup comparisons, we
compared the hazard ratios and conﬁdence
intervals derived from each intellectual
disability versus control comparison (e.g.,
adults with intellectual disability and Down
syndrome vs controls) and calculated P values
for between-group differences. In supple-
mentary analyses focusing only on intellectual
disability patients, we ﬁt models that directly
compared each subgroup category (e.g., those
with vs without Down syndrome), adjusted
for age and gender differences and stratiﬁed
according to practice.
RESULTS
A total of 656 (3.9%) adults with
intellectual disability died over the study
period, compared with 1358 (1.2%) of the
matched controls (Table 1). In the intellectual
disability group, death rates were elevated
among those with Down syndrome (6.6%),
a high number of support needs (5.9%), and
epilepsy (5.8%) and among those living in
communal or shared arrangements (7.8%).
All-Cause Mortality
The crude mortality rate was 132.4 per
10 000 people per year among adults with
intellectual disability, compared with 39.7
among controls (Table 2). The resulting
hazard ratio (3.62; 95% conﬁdence interval
[CI] = 3.33, 3.93)was only partially explained
by differences between the groups in
comorbidities, smoking, and deprivation
(adjusted HR=3.05; 95% CI= 2.73, 3.41).
The higher mortality risk among adults
with intellectual disability was seen at all ages,
and although it was higher amongmen than it
was among women, the difference was not
statistically signiﬁcant after adjustment
(P= .07).
Among adults with intellectual disability,
those with Down syndrome had a very high
relative risk of death in comparison with
controls (HR=9.21; 95% CI= 7.22, 11.76),
and this risk was signiﬁcantly different from
that seen among those in the intellectual
disability group without Down syndrome
(P < .001) and was not explained by further
adjustment. Similarly, intellectual disability
patients with high levels of support needs
had a death rate nearly 5 times higher than
that of controls, and the rate among those in
communal or shared living arrangements was
more than 4 times higher; both rates were
signiﬁcantly different from the comparable
rates among other adults in the intellectual
disability group before as well as after ad-
justment (P< .01). Epilepsy within the in-
tellectual disability population was a strong
determinant of mortality risk, both relative
to the control group (HR=6.04; 95%
CI= 5.04, 7.24) and relative to other adults
TABLE 1—Characteristics of and Numbers of Deaths in the Intellectual Disability and
Matched Control Groups: Selected UK General Practices, 2009–2013
Intellectual Disability
Group Control Group
Characteristic of Intellectual
Disability Adult Mean Age, y (SD) No. Deaths, No. (%) No. Deaths, No. (%)
Total 39.9 (16.2) 16 666 656 (3.94) 113 562 1 358 (1.20)
Gender
Male 41.3 (16.4) 6 989 291 (4.16) 47 587 538 (1.13)
Female 38.8 (15.9) 9 677 365 (3.77) 65 975 820 (1.24)
Age, y
18–34 24.2 (5.1) 6 981 48 (0.69) 46 939 69 (0.15)
35–54 44.2 (5.4) 6 283 167 (2.66) 43 123 276 (0.64)
‡ 55 64.0 (7.1) 3 402 441 (12.96) 23 500 1 013 (4.31)
Down syndrome
Yes 39.1 (14.4) 1 793 118 (6.58) 12 226 92 (0.75)
No 40.0 (16.4) 14 873 538 (3.62) 101 336 1 266 (1.25)
High level of support needsa
Yes 41.4 (16.4) 3 263 194 (5.94) 22 298 302 (1.35)
No 39.5 (16.1) 13 403 462 (3.45) 91 264 1 056 (1.16)
Communal/shared accommodations
Yes 47.2 (15.7) 3 392 265 (7.81) 23 117 416 (1.80)
No 38.0 (15.8) 13 274 391 (2.90) 90 445 942 (1.04)
Autism spectrum disorder
Yes 30.5 (13.3) 1 532 15 (0.98) 10 374 44 (0.42)
No 40.8 (16.1) 15 134 641 (4.24) 103 188 1 314 (1.27)
Epilepsy
Yes 41.0 (15.3) 2 884 167 (5.79) 19 705 205 (1.04)
No 39.6 (16.3) 13 782 489 (3.55) 93 857 1 153 (1.23)
Any subgroup categorizationb
Yes 40.6 (16.4) 8 541 446 (5.22) 58 194 703 (1.21)
No 39.1 (16.0) 8 125 210 (2.58) 55 368 655 (1.18)
aClassiﬁed by a general practitioner as having severe or profound intellectual disability or has ‡ 2 of the
following: epilepsy, cerebral palsy or signiﬁcant mobility problem (wheelchair use or greater), severe
visual impairment, severe hearing impairment, continence problem, or use of percutaneous endoscopic
gastrostomy feeding.
bDown syndrome, high level of support needs, communal/shared accommodations, autism, or epilepsy.
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in the intellectual disability group without
epilepsy (P < .001). Additional (unmatched)
analyses that directly compared adults with
intellectual disability in each subgroup (Table
B, available as a supplement to the online
version of this article at http://www.ajph.
org) conﬁrmed the ﬁndings shown inTable 2.
Cause-Speciﬁc Mortality
The higher mortality risk among adults
with intellectual disability produced
different patterns of cause-speciﬁc mortality,
with the most common main causes of
mortality being circulatory diseases (21.6%),
respiratory diseases (18.8%), neoplasms
(14.9%), and nervous system diseases
(11.6%). The pattern among controls was
different, with neoplasms (37.4%), circula-
tory diseases (26.5%), respiratory diseases
(9.9%), and external causes (7.4%) being
most common.
The cause-speciﬁc death rate was higher
among adults with intellectual disability than
it was among controls for all main causes
(Table 3). However, suicides and trafﬁc ac-
cidents (a subgroup of external causes) were
more common among controls. Hazard ratios
for main causes of death showed that the
greatest relative increases were for diseases of
the genitourinary system, including urinary
tract infections (HR=10.89; 95% CI= 6.09,
19.47), and nervous system disorders,
including epilepsy (HR=13.79; 95%
CI= 9.70, 19.62). Other common causes of
death (e.g., circulatory, digestive, respiratory
TABLE 2—All-Cause Mortality Crude Rates and Hazard Ratios for the Intellectual Disability and Matched Control Groups: Selected UK
General Practices, 2009–2013
Mortality Rate
Unadjusted Model Adjusted Modela
Characteristic of Intellectual Disability Adult
Intellectual Disability
Group (n = 16 666)
Control Group
(n = 113 562) HR (95% CI) P b HR (95% CI) P b
Total 132.4 39.7 3.62 (3.33, 3.93) 3.05 (2.73, 3.41)
Gender .01 .07
Male 139.5 37.5 4.10 (3.61, 4.66) 3.50 (2.94, 4.16)
Female 127.3 41.5 3.30 (2.96, 3.68) 2.81 (2.43, 3.24)
Age, y
18–34 25.3 5.6 4.29 (3.13, 5.88) 2.43 (1.56, 3.77)
35–54 83.1 19.6 4.17 (3.52, 4.92) .88 3.22 (2.53, 4.08) .25
‡55 420.0 129.6 3.39 (3.07, 3.75) .21 3.03 (2.65, 3.46) .32
Down syndrome < .001 < .001
Yes 220.0 24.9 9.21 (7.22, 11.76) 10.39 (7.13, 15.13)
No 121.8 41.6 3.19 (2.92, 3.49) 2.66 (2.36, 3.00)
High level of support needsc < .001 .001
Yes 190.2 43.9 4.77 (4.08, 5.59) 4.95 (4.03, 6.07)
No 117.4 38.7 3.28 (2.98, 3.62) 3.15 (2.79, 3.55)
Communal/shared accommodations < .001 < .001
Yes 254.7 56.5 4.99 (4.36, 5.73) 4.30 (3.52, 5.26)
No 99.9 35.1 3.05 (2.74, 3.39) 2.64 (2.30, 3.02)
Autism spectrum disorder .05 .40
Yes 36.3 16.0 2.39 (1.45, 3.96) 2.22 (1.01, 4.86)
No 141.2 41.8 3.66 (3.37, 3.98) 3.07 (2.74, 3.43)
Epilepsy < .001 < .001
Yes 188.0 33.7 6.04 (5.04, 7.24) 7.76 (6.10, 9.86)
No 120.3 41.0 3.18 (2.90, 3.50) 2.91 (2.60, 3.27)
Any subgroup categorizationd < .001 < .001
Yes 173.8 39.8 4.85 (4.36, 5.38) 4.27 (3.64, 5.01)
No 87.9 39.6 2.35 (2.04, 2.70) 2.12 (1.79, 2.51)
Note. CI = conﬁdence interval; HR =hazard ratio. Rates are per 10 000 people per year.
aAdjusted for 9 comorbidities (atrialﬁbrillation, cancer, chronic obstructive pulmonarydisease, dementia, diabetes, epilepsy, heart failure, severemental illness,
and stroke), deprivation, and smoking status with the exception of the subgroup analyses focusing on epilepsy and high number of support needs, in which
epilepsy was not included in the adjustment.
bFor differences between subgroups (for age, 18–34 years was the baseline group).
cClassiﬁedbyageneralpractitionerashavingsevereorprofound intellectualdisabilityorhas‡ 2of thefollowing:epilepsy, cerebralpalsyor signiﬁcantmobilityproblem
(wheelchair use or greater), severe visual impairment, severe hearing impairment, continence problem, or use of percutaneous endoscopic gastrostomy feeding.
dDown syndrome, high level of support needs, communal/shared accommodations, autism, or epilepsy.
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diseases) all had hazard ratios between 3 and 7.
Notable disparities within the respiratory
death category included pneumonia and as-
piration pneumonia, for which death rates
among adults with intellectual disability were
more than 10 times higher than were rates
among controls.
The most common underlying cause of
death among adults with Down syndrome
was respiratory diseases (n = 24; 20.3%).
However, Down syndrome (or another
chromosomal abnormality) was listed as the
underlying cause in 30 deaths, and in 26
of these cases respiratory disease was listed
as a secondary cause. If respiratory diseases
had instead been classiﬁed as the underlying
cause in these 26 deaths, the percentage
of Down syndrome deaths caused by re-
spiratory diseases would have increased
to 42.4%.
Potentially Avoidable Mortality
Amenable to Health Care
The percentage of all deaths classiﬁed as
potentially avoidable (amenable to care or
preventable) was similar among adults with
intellectual disability (46.3%) and controls
(47.5%). However, the percentages of deaths
amenable to care and preventable were very
different between the 2 groups (Figure 1),
with a higher percentage of deaths amenable
to care observed among intellectual disability
adults (37.0%, compared with 22.5% among
controls). This difference was reﬂected in
the hazard ratio for deaths amenable to care
(HR=5.86; 95% CI= 5.06, 6.80) in contrast
to preventable deaths (HR=1.69; 95%
CI= 1.42, 2.02). In addition, standard ONS
deﬁnitions do not include a number of causes
of deaths among people with intellectual
disability that might be considered amenable
to care, such as deaths from urinary tract
infections (n = 12; 1.8%) and aspiration
pneumonitis (n = 21; 3.2%).
Recording of Intellectual Disability
on Death Certiﬁcates
In 456 (69.5%) deaths among adults
with intellectual disability, there was no
mention of intellectual disability or a related
condition as either a main or contributory
cause of death. In the remaining 200 cases
that had a recorded cause associated with
intellectual disability, the most common
causes listed were Down syndrome (n= 88),
cerebral palsy (n = 39), and developmental
disorder of scholastic skills (n = 50).
DISCUSSION
We have conﬁrmed and quantiﬁed
a 3 to 4 times higher risk of death among
adults with intellectual disability than we
conﬁrmed among the general population,
and this risk is seen across all common causes
of death and is not explained by the higher
frequency of comorbid conditions in the
intellectual disability group. Furthermore,
our results show that adults with epilepsy or
Down syndrome experiencemarkedly higher
mortality than other people with intellectual
disability. Although potentially avoidable
deaths accounted for a similar proportion
of deaths among adults with intellectual
TABLE 3—Cause-Speciﬁc Death Rates for the Intellectual Disability and Matched
Control Groups: Selected UK General Practices, 2009–2013
Intellectual
Disability Group
(n = 16 666)
Control Group
(n = 113 562)
Cause of Death No. Rate No. Rate HR (95% CI)
Diseases of the circulatory systema 142 28.7 360 10.5 3.05 (2.56, 3.64)
Neoplasms 98 19.8 508 14.9 1.44 (1.18, 1.76)
Diseases of the respiratory systemb 123 24.8 135 3.9 6.68 (5.38, 8.29)
Diseases of the digestive system 46 9.3 87 2.5 4.02 (2.92, 5.54)
Diseases of the genitourinary system 23 4.6 15 0.4 10.89 (6.09, 9.47)
Mental and behavioral disorders 35 7.1 31 0.9 7.99 (5.19, 12.31)
Diseases of the nervous systemc 76 15.3 39 1.1 13.79 (9.70, 19.62)
External causesd 27 5.5 101 3.0 1.85 (1.26, 2.71)
Endocrine, nutritional, and metabolic
diseases
13 2.6 16 0.5 5.38 (2.79, 10.07)
Infectious and parasitic disorders 3 0.6 14 0.4 2.30 (0.70, 7.48)
Diseases of the musculoskeletal system 6 1.2 8 0.2 5.50 (2.22, 13.61)
Congenital/chromosomal abnormalities 45 9.1 2 0.1 . . .e
Other (skin/blood diseases, residual codes) 10 2.0 13 0.4 5.03 (2.40, 10.54)
Not available 9 1.8 29 0.8 2.27 (1.19, 4.43)
Total 656 132.4 1358 39.7 3.62 (3.33, 3.93)
Note. CI = conﬁdence interval; HR =hazard ratio. Rates are per 10 000 people per year. Unadjusted
hazard ratios are shown for common broad causes of mortality among adults with intellectual disability
with the exception of congenital/chromosomal abnormalities, for which a hazard ratio would not be
informative.
Source. We summarizedmain causes of death using chapter headings from the International Classiﬁcation
of Diseases, 10th Revision.14
aNotable subgroups: cerebrovascular disease (intellectual disability group, n = 34, rate = 6.9; control
group, n = 57, rate = 1.7) and ischemic heart diseases (intellectual disability group, n = 62, rate = 12.5;
control group, n = 188, rate = 5.5).
bNotable subgroups: pneumonia (intellectual disability group, n = 67, rate = 13.5; control group, n = 39,
rate = 1.1) and aspiration pneumonitis (intellectual disability group, n = 21, rate = 4.2; control group,
n = 6, rate = 0.2).
cNotable subgroup: epilepsy (intellectual disability group, n = 29, rate = 5.9; control group, n = 3,
rate = 0.1).
dNotable subgroups: accidental poisoning (intellectual disability group, n = 3, rate = 0.6; control group,
n = 13, rate = 0.4), intentional or undetermined (intellectual disability group, n = 4, rate = 0.8; control
group, n = 49, rate = 1.4), trafﬁc accident (intellectual disability group, n = 1, rate = 0.2; control group,
n = 20, rate = 0.6), and other accident (intellectual disability group, n = 17, rate = 3.4; control group,
n = 15, rate = 0.4).
eHazard ratio could not reliably be estimated.
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disability and the general population, there
was a notable discrepancy in deaths amenable
to health care, with the rate of such deaths
being almost 6 times higher among adults
with intellectual disability than they were in
the general population.
Context
A number of data sources have been used
in studies of mortality among people with
intellectual disability, including local registers,
death certiﬁcation data alone, and national
registers.18Our ﬁnding of an increased overall
risk of death among people with intellectual
disability is consistent with the results of
most studies. The largest existing UK study,
an investigation based on a follow-up of
a regional disease register in Leicestershire,
reported a similar increased risk of death.3,19
Our ﬁnding that fewer than a third of death
certiﬁcates recorded intellectual disability
as a secondary cause of death emphasizes
the limitations of studies based on death
certiﬁcates alone.
Overall, our description of cause-speciﬁc
mortality is similar to those in other cohorts;
however, an increased risk of cancer death has
not been consistently described, with some
studies suggesting a similar19 or lower risk
of cancer death.5 Our ﬁndings may represent
an important change resulting from an aging
population of people with intellectual dis-
ability. Other studies have reported increased
mortality rates among people with intel-
lectual disability and epilepsy,10 with a
particular concern over the contribution of
sudden unexpected death associated with
epilepsy.20,21
Mortality among people with Down
syndrome has beenmore widely studied.22–25
The ﬁndings from these investigations are
consistent with the high risk of death we
found among people with Down syndrome.
For example, researchers in a large Danish
population study concluded that people with
standard trisomy 21 had a mortality hazard
ratio of 8.9,24 and a smaller American study
showed that community-residing adults
with Down syndrome were almost 4 times
as likely to die as adults with other types
of intellectual disability.25
The UK conﬁdential inquiry mentioned
earlier reported a high proportion of deaths
amenable to health care intervention, but
the study researchers were able to compare
this proportion only with the national aver-
age; they were unable to quantify absolute
and relative risks.7 Our study extends this
work and provides quantitative estimates
of these risks among people with intellectual
disability. However, it should be noted
that existing deﬁnitions of amenablemortality
do not include some important treatable
causes of deaths among people with in-
tellectual disability, including urinary tract
infections and aspiration, and thus are likely to
underestimate the true burden of amenable
mortality.
Strengths and Limitations
The main strength of our study is the
inclusion of a large unselected population
of adults with known intellectual disability
and the fact that we were able to compare
their experience with age- and gender-
matched individuals from the same general
practice. Our use of both primary care
and death registration data is a crucial step
in addressing an acknowledged lack of
population-based comparative studies of
mortality among people with intellectual
disability.8 This linkage allows for better
ascertainment of adults with intellectual
disability as well as control and stratiﬁcation
by factors not available in death registration
data such as those focusing on comorbidity
and smoking. Within-practice matching
overcomes concerns regarding geographical
All Mortality (100%, Rate = 132.4) 
Preventable
(19%, Rate = 25.6)
Amenable 
(37%, Rate = 49.1)
Amenable
Hazard Ratio = 5.86 
(95% CI = 5.06, 6.80)
Preventable
Hazard Ratio = 1.69 
(95% CI = 1.42, 2.02)
Adults With Intellectual Disability
Controls
Preventable
(40%, Rate = 15.9)
Amenable
(23%, Rate = 8.9)
All Mortality (100%, Rate = 39.7) 
Note. CI = conﬁdence interval. Sizes of squares correspond to both rates and percentages of overall mortality; rates are per 10 000 people per year. Overall avoidable
mortality is the total shaded area covered by the amenable andpreventable squares,with theoverlap area being counted only once: intellectual disability rate = 61.4 (46.3%
of all mortality), control rate = 18.9 (47.5%), and hazard ratio = 3.44 (95% CI = 3.05, 3.89).
FIGURE 1—Percentages of Deaths in the Intellectual Disability and Matched Control Groups Categorized as Amenable and Preventable:
Selected UK General Practices, 2009–2013
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differences in health care access or quality
and inconsistencies in clinical recording
between practices.
The main limitation of our study is
the potential for incomplete and inaccurate
recording in primary care and death certiﬁ-
cation data. In England, doctors have been
encouraged to electronically maintain
a register of all adults with intellectual dis-
ability,12 so although it is reasonable to assume
that most patients with severe intellectual
disability will be identiﬁed, some milder cases
may be missed. This may result in an over-
estimation of the mortality risk in the in-
tellectual disability population as a whole, but
we still found a doubling of risk when we
restricted our analyses to patients with no
signiﬁcant impairments recorded. Recording
of intellectual disability severity itself was
less complete; however, we created a com-
posite measure incorporating other relevant
information in the patient record (including,
if available, severe or profound classiﬁcations),
although the consistency of recording of
some of these factors may vary across
practices.
Many patients with Down syndrome
had this condition recorded as the underlying
cause of death, with respiratory disease as
a secondary cause. Although it could be
argued that respiratory disease was the more
appropriate underlying cause of death, in
this scenario either cause would still be
classiﬁed as amenable to care and, hence,
avoidable. However, it may be that some
causes of death are less avoidable among adults
with intellectual disability because of the
underlying cause of the intellectual disability
itself. For example, the immune defects
observed among people with Down syn-
drome may lead to infections being more
common and less amenable to treatment.26
Implications and Conclusions
Mortality data are essential in identifying
priorities for local, national, and global health
strategies. Understanding mortality among
people with intellectual disability is important
in ensuring that interventions are appropri-
ately targeted to this group’s speciﬁc health
needs. Our work contributes to this aim by
quantifying mortality disparities between
adults with intellectual disability and the
general population.
The consistently higher mortality risk
among adults with intellectual disability
was seen at all ages and was not explained
by their higher levels of comorbidity.13
Although some conditions may be under-
diagnosed or underreported,27 our results
suggest that underlying differences in func-
tional status are more pertinent, highlighting
the overall greater health care needs of people
with intellectual disability. Consistent guid-
ance on recording of intellectual disability
as a contributory but not underlying cause
on death certiﬁcates would be helpful for
ongoing surveillance of the health of
people with intellectual disability in all
countries.28
Although many of the leading causes of
death among adults with intellectual disability
are similar to those found in the general
population, there are important differences.
One is the higher burden of respiratory
deaths, which is important given that national
strategies in developed countries assign
a lower priority to respiratory health. The
large contributions of pneumonia and
aspiration are particularly important as a po-
tential focus for improving health care among
people with intellectual disability. The large
contributions of urinary and neurological
causes of death highlight further potential
opportunities to improve care for people
with intellectual disability through better
management of urinary tract infections
and optimization of seizure control.
Our most important ﬁnding is that more
than a third of deaths among adults with
intellectual disability were amenable to health
care, with these deaths driving the overall
higher risk of potentially avoidable deaths.
The difference in the relative contribution of
preventable and amenable deaths to avoidable
mortality among people with intellectual
disability and the general population may
be partly explained by differences in lifestyle
exposures, in particular tobacco and alcohol
use. Adherence to current medical guidelines
may also differ owing to difﬁculties en-
countered in communicating with patients
with intellectual disability.27 However, the
high absolute risk of deaths amenable to
health care intervention reﬂects established
concerns regarding difﬁculty accessing
health care, delays in diagnosis, and poorer
management experienced by people with
intellectual disability.1,7
Our ﬁndings emphasize that strategies
for improving health among people with
intellectual disability need to prioritize access
to and quality of health care as well as pre-
ventive interventions. Existing population-
wide strategies for working-age adults in
high-income countries focus on cardiovas-
cular risk and lifestyle factors, which, although
important for people with intellectual dis-
ability, do not address their different health
care needs. Confronting the health and
mortality disparities experienced by people
with intellectual disability is a key challenge
for health care systems and a potentially
important indicator of their equity and
effectiveness.
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